Private Credit Raised $16 Billion in Q2. Only Half of It Found a Home

Direct lending funds raised $16.25 billion in Q2 2026, up from just $1.3 billion in Q1, according to a Reuters report citing Preqin data. But the money isn't finding a home fast enough.

That fundraising number is not a typo. North America-focused closed-end direct lending funds (vehicles that raise a fixed pool of capital upfront, lock it in for a set term, and then invest it over that term rather than accepting new money continuously) pulled in more than 12 times what they raised the previous quarter. It was, according to the same Preqin data, the strongest fundraising quarter for the category in two years. If you only looked at that one number, you'd think private credit was having its best stretch since the regional bank stress of 2023 sent borrowers running toward non-bank lenders.

You'd be half right. Investors want in. GPs (general partners, the firms that manage the fund and decide which loans to make) are having no trouble raising it. What they're having trouble doing is putting it to work. In that same quarter, actual loan origination (the dollar volume of new loans direct lenders actually closed and funded) fell by roughly 55% quarter-on-quarter, dropping to $33.6 billion from $74.7 billion in Q1 2026, according to PitchBook/LCD data cited in the same report. Deal count told the same story: 154 completed transactions in Q2, down from 217 in Q1, the weakest quarter for lending activity since Q2 2023.

Run those two trend lines side by side and you get a gap, not a rebound. I want to walk you through why that gap opened up, what it means if you're already an LP (limited partner, the investor side of a fund) in a direct lending vehicle, and what questions you should be asking before you commit fresh capital to the next one.

Q1 vs. Q2 2026, by the numbers

Here's the disconnect laid out cleanly. Fundraising went one direction. Deployment went the other. Same quarter, same asset class, opposite momentum.

Metric	Q1 2026	Q2 2026	Change
Direct lending fundraising (North America-focused closed-end funds)	$1.3 billion	$16.25 billion	Up roughly 12.5x
Direct lending loan origination	$74.7 billion	$33.6 billion	Down approximately 55%
Completed direct lending deals	217	154	Down approximately 29%

Source: Preqin fundraising data and PitchBook/LCD origination and deal-count data, both cited in the Reuters report published July 10, 2026.

Notice what isn't in that table: a matching decline in fundraising. Capital formation and capital deployment usually move together, at least directionally, because GPs generally raise money when they see deals to fund it with. Q2 2026 broke that pattern. Fundraising accelerated while deployment fell by more than half and deal count kept sliding for a second straight quarter. That's the story, not the headline fundraising number by itself.

What "dry powder" actually means, and why it's piling up

Dry powder is the industry's term for capital that's been raised and committed but not yet invested. It sits in the fund, earning whatever the fund's cash management policy allows, waiting for a loan to deploy into. Every private credit fund carries some dry powder as a matter of course, because you can't deploy every dollar the moment it comes in the door, and good GPs keep some in reserve for follow-on financing or add-on deals. The question is always one of degree. A little dry powder is prudent. A lot of dry powder, growing quarter over quarter while origination shrinks, tells you the market has more capital chasing loans than it has loans worth making.

Three forces are driving that imbalance right now, and none of them are exotic.

Fewer deals to finance

Direct lenders make most of their money financing leveraged buyouts and other private equity-sponsored M&A. When deal flow slows, so does the lending that rides alongside it. The 29% drop in completed direct lending transactions, from 217 in Q1 to 154 in Q2, lines up with a broader pullback in sponsor-driven M&A activity this year. Fewer buyouts means fewer financing packages for direct lenders to write, full stop. It doesn't matter how much dry powder a fund has if the underlying deal isn't there to fund.

Borrowers going around direct lenders

Direct lending won a lot of market share from banks and the syndicated loan market over the past several years by offering speed and certainty of execution. But that edge cuts both ways when credit markets are healthy. When syndicated loan and high-yield bond markets are open and pricing is attractive, borrowers who might otherwise take a direct loan go refinance through those cheaper, more liquid channels instead. Some of the Q2 origination drop reflects borrowers voting with their feet and choosing public or syndicated markets over a privately negotiated loan.

Lenders staying disciplined instead of chasing volume

This is the one worth sitting with the longest. With so much capital competing for a shrinking pool of quality deals, GPs face real pressure to cut pricing, loosen covenants, or stretch on leverage multiples just to win a deal. The Q2 data suggests that, on balance, direct lenders chose not to do that: origination volume fell rather than credit standards. That's the healthy read of this data. It's also the read that could flip fast if the gap between raised and deployed capital keeps widening and firms start feeling pressure from their own investors to show deployment progress.

What this means if you're already committed to a fund

If you've made a commitment to a direct lending fund, closed-end or otherwise, this data affects you even though you can't see it show up on a statement. Here's how.

Capital calls slow down. In a closed-end fund, you don't hand over your full commitment on day one. You commit a dollar amount, and the GP calls capital from you in tranches as it finds loans to fund. When origination falls by 55% in a quarter, the pace of those capital calls slows with it. That's not a red flag by itself. It's the natural consequence of a GP being disciplined instead of forcing deployment. But it does mean the capital you've earmarked for the fund may sit uninvested, elsewhere, for longer than your original planning assumed.

The clock on fund life and return timelines can stretch. Direct lending funds are typically structured with a defined investment period, often three to five years, during which the GP deploys capital, followed by a harvest period where loans mature and get repaid. If a slower start to deployment pushes actual investing later into that window, everything downstream (interest income ramping up, principal repayments, ultimate fund wind-down) shifts later too. Nobody is losing principal because of a slow deployment pace on its own. But your internal rate of return math, and your own liquidity planning around when distributions arrive, both need to account for a deployment curve that started slower than the pitch deck assumed.

Watch for pressure to deploy anyway. This is the risk that actually matters. GPs sitting on large amounts of committed, fee-generating dry powder face real incentive to put it to work, because most direct lending funds charge management fees on committed or invested capital and GPs want to show LPs a deployment track record before they go raise the next fund. If the gap between what's been raised and what's been deployed keeps widening through the back half of 2026, the honest question to ask is whether some managers eventually loosen their standards to close it. A fund that stayed disciplined in Q2 2026 isn't guaranteed to stay disciplined in Q4 if the pressure to show results builds.

This shifting is playing out in real time even as new funds keep closing. Sagard Credit Partners III closed its first tranche at more than $1 billion toward a $2 billion target this same week, adding fresh dry powder to a market that, per the same-week data, is already struggling to deploy what it raised in Q2. That's not a criticism of Sagard specifically — a well-regarded manager closing on a large first tranche is a normal, even encouraging, sign of LP confidence. But it does mean the aggregate dry powder pile that direct lending managers across the market are sitting on keeps growing, week over week, at the same time deployment is falling. Anyone allocating into a new vintage right now is stepping into that environment, not around it.

Questions to ask before you commit to a new private credit fund

If you're an accredited investor evaluating a new direct lending commitment against this backdrop, don't just look at the fund's target size and headline return projections. Ask the GP directly about pace and pipeline. Specifically:

• What is the fund's current deployment pace relative to its own internal target, and how has that pace trended over the last two quarters?
• How much dry powder does the fund (or the manager's prior vintage, if this is a new fund) currently hold relative to total committed capital?
• What does the manager's active pipeline of prospective loans look like right now, in dollar terms and deal count, not just in general terms?
• Has the manager changed underwriting standards, covenant packages, or pricing in the current quarter compared to a year ago, and if so, how?
• What happens to the fund's fee structure and investment period if deployment continues to run behind the original plan?
• How does the manager define its "worst case" scenario for a slow-deployment environment, and what's the plan if capital sits uninvested longer than expected?

None of these questions guarantee a good outcome. They do force a manager to show you real numbers instead of a return projection built on an assumed deployment schedule that may no longer hold. A GP with a genuinely strong pipeline will answer these specifically and happily. A GP that gets vague is telling you something too.

The bigger picture

Private credit as a category has grown enormously over the past decade, and direct lending is the largest piece of it. Data providers like Preqin and PitchBook track this market closely because institutional allocators, pensions, and increasingly individual accredited investors have poured money into it looking for yield that doesn't move in lockstep with public markets. That growth story is real, and it isn't reversing because of one soft quarter for origination.

But a market where fundraising outpaces deployment by this much, this fast, is a market signaling something worth paying attention to: there's more capital chasing private credit returns than there are loans, at acceptable terms, to put it into. That's not automatically bad news for anyone already in a fund with disciplined management. It can even be good news, if it means your GP is passing on marginal deals rather than writing them just to stay busy. But it changes your planning assumptions around when capital gets called and when it comes back, and it raises the bar for what you should expect a new fund's GP to show you about their actual pipeline before you sign a subscription agreement. The $16.25 billion raised in Q2 2026 is real money that real investors trusted real managers to deploy well. Whether it gets deployed well, or just deployed, is the part nobody can tell you from a fundraising press release.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.